SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Microcap & Penny Stocks : International Nursing Services Inc, old (NURS) new (MDIX)

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Linda Kaplan who wrote (2755)5/19/1999 9:41:00 PM
From: Robert E. Winston  Read Replies (1) of 2911
 
I like a conspiracy theory as much as anyone but I'll need a little more evidence before seeing one here.

If you look at a chart of today's action you'll see that a lot more shares were spent driving the price down than were bought pulling it up again. That doesn't look like manipulation unless the effort to cause panic selling simply failed.

A more reasonable explanation is that some MDIX share holders are seeing that our company is being left behind in the inevitable industry consolidation. So they sold.

Others, hoping for a buyout, bought on the dip.

Even with the late recovery today, MDIX didn't perform well compared to competitors.

techstocks.com

It's become painfully clear that MDIX can't go it alone. It doesn't have the infrastructure or the capital.

The two big players, Healtheon and Synetic, now have market caps of 5.6 and 2.0 billion respectively.

I've decided to ride this train to the end, but what worries me is this:

If MDIX really does have superior software and patents, and if there really is anything to the Wellpoint - what shall we call it? A pre-contract? - then why isn't MDIX in play? Look at what HLTH is willing to pay for a company (WebMD) that has no unique product, essentially no revenue, and a huge loss.

What should MDIX be worth with it patents and potential revenue?

If you buy into the rumors the Wellpoint deal would be worth $30 million next year and Humana which has been mentioned as a second MDIX client (and also as a merger partner with Wellpoint) would be worth even more, then that's $60-70 million in revenue per year. Just acquiring that would double Healtheon's projected next year's revenue.

Yet the market values MDIX at $13.2 million.

Either MDIX doesn't have what it says it has or it keeps secrets a lot better than the Los Alamos weapons lab.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext